ASA
BIIB icon

Axxion S.A.’s Biogen BIIB Stock Holding History

Axxion S.A.’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
+2,200
New +$421K 0.03% 230

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Axxion S.A.'s BIIB Position: Q2 2026 in Review

Axxion S.A. opened a new position in Biogen (BIIB) in Q2 2026: 2,200 shares worth $475K. The stake represents 0.03% of the portfolio and ranks #230 among its holdings.

973 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Axxion S.A. held 2,200 shares of Biogen worth $475K as of Q2 2026.
  • Biogen was a new Axxion S.A. position in Q2 2026.
  • Biogen made up 0.03% of Axxion S.A.'s portfolio in Q2 2026, its #230 holding.
  • 973 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.